Physician profile
Daniel J Greene
NPI 1750474813
$849.84
in general payments reported to CMS, 2019-2025
21 companies · $211 in 2025
The $211 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.07 · 2020: $14.65 · 2022: $72.02 · 2023: $298 · 2024: $229 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $718 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $718.10 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $188.69 | 2023-2025 | Veozah |
| Hologic Sales and Service, LLC | $120.43 | 2022-2025 | Aptima, Thinprep 2000 Processor, Myosure Tissue Removal Device |
| Aspira Women'S Health INC | $95.13 | 2023 | Ova1 |
| Exeltis, USA INC. | $68.87 | 2023-2025 | Slynd |
| Coopersurgical, INC. | $61.03 | 2025 | Endosee, Paragard T 380a |
| Shield Therapeutics INC | $38.21 | 2023-2024 | Accrufer |
| Smith+Nephew, INC. | $34.69 | 2022-2023 | |
| Meditrina | $26.68 | 2024-2025 | |
| Mimedx Group, INC. | $24.93 | 2024 | |
| Biogen, INC. | $24.42 | 2024 | |
| Organon LLC | $24.20 | 2023 | Jada System |
| Sumitomo Pharma America, INC. | $23.04 | 2024 | Myfembree |
| Medtronic, INC. | $21.37 | 2023 | Truclear |
| Novo Nordisk INC | $17.16 | 2022 | |
| Lupin INC. | $14.65 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $14.14 | 2019 | |
| Conmed Corporation | $14.07 | 2023 | Airseal |
| Pfizer INC. | $13.97 | 2023 | |
| Lsi Solutions INC | $13.23 | 2024 | Fornisee |
| Therapeuticsmd, INC. | $10.93 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Greene listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.